Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124,068 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiation.
Hanna GK, Madany M, Tay ASS, Edwards LA, Kim S, Michael JS, Nuno M, Thomas T, Li A, Berel D, Black KL, Fan X, Zhang W, Rudnick JD, Wang R, Yu JS. Hanna GK, et al. Among authors: kim s. J Neurosurg. 2022 Sep 16;138(5):1313-1324. doi: 10.3171/2022.7.JNS22259. Print 2023 May 1. J Neurosurg. 2022. PMID: 36115050
A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma.
Hu JL, Omofoye OA, Rudnick JD, Kim S, Tighiouart M, Phuphanich S, Wang H, Mazer M, Ganaway T, Chu RM, Patil CG, Black KL, Shiao SL, Wang R, Yu JS. Hu JL, et al. Among authors: kim s. Clin Cancer Res. 2022 Feb 15;28(4):689-696. doi: 10.1158/1078-0432.CCR-21-2867. Clin Cancer Res. 2022. PMID: 34862245 Clinical Trial.
Expanded Parameters in Active Surveillance for Low-risk Papillary Thyroid Carcinoma: A Nonrandomized Controlled Trial.
Ho AS, Kim S, Zalt C, Melany ML, Chen IE, Vasquez J, Mallen-St Clair J, Chen MM, Vasquez M, Fan X, van Deen WK, Haile RW, Daskivich TJ, Zumsteg ZS, Braunstein GD, Sacks WL. Ho AS, et al. Among authors: kim s. JAMA Oncol. 2022 Sep 15;8(11):1588-96. doi: 10.1001/jamaoncol.2022.3875. Online ahead of print. JAMA Oncol. 2022. PMID: 36107411 Free PMC article.
A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer.
Anderson E, LeVee A, Kim S, Atkins K, Guan M, Placencio-Hickok V, Moshayedi N, Hendifar A, Osipov A, Gangi A, Burch M, Waters K, Cho M, Klempner S, Chao J, Kamrava M, Gong J. Anderson E, et al. Among authors: kim s. JAMA Netw Open. 2021 Dec 1;4(12):e2138432. doi: 10.1001/jamanetworkopen.2021.38432. JAMA Netw Open. 2021. PMID: 34889947 Free PMC article.
Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy.
Kim S, DiPeri TP, Guan M, Placencio-Hickok VR, Kim H, Liu JY, Hendifar A, Klempner SJ, Nipp R, Gangi A, Burch M, Waters K, Cho M, Chao J, Atkins K, Kamrava M, Tuli R, Gong J. Kim S, et al. Among authors: kim h. World J Gastrointest Surg. 2020 Sep 27;12(9):377-389. doi: 10.4240/wjgs.v12.i9.377. World J Gastrointest Surg. 2020. PMID: 33024512 Free PMC article.
124,068 results
You have reached the last available page of results. Please see the User Guide for more information.